Evidence map›Paper›PMID 35620177›Full record

ArticleRevista panamericana de salud publica = Pan American journal of public health2022

[Mobile technologies in healthcare: reflections on development, application, legal aspects, and ethicsTecnologías sanitarias móviles: reflexiones sobre desarrollo, aplicación, legislación y ética].

Lívia Luize Marengo, Alan Martinez Kozyreff, Fabio da Silva Moraes, Laura Inês Gomes Maricato, Silvio Barberato-Filho

Abstract readEnglish Abstract
In one paragraph

Article in Revista panamericana de salud publica = Pan American journal of public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Observational
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lívia Luize MarengoUniversidade de Sorocaba (UNISO) Programa de Pós-Graduação em Ciências Farmacêuticas Sorocaba (SP) Brasil Universidade de Sorocaba (UNISO), Programa de Pós-Graduação em Ciências Farmacêuticas, Sorocaba (SP), Brasil.
Alan Martinez KozyreffUniversidade de Sorocaba (UNISO) Programa de Pós-Graduação em Ciências Farmacêuticas Sorocaba (SP) Brasil Universidade de Sorocaba (UNISO), Programa de Pós-Graduação em Ciências Farmacêuticas, Sorocaba (SP), Brasil.
Fabio da Silva MoraesUniversidade de Sorocaba (UNISO) Programa de Pós-Graduação em Ciências Farmacêuticas Sorocaba (SP) Brasil Universidade de Sorocaba (UNISO), Programa de Pós-Graduação em Ciências Farmacêuticas, Sorocaba (SP), Brasil.
Laura Inês Gomes MaricatoUniversidade de Sorocaba (UNISO) Programa de Pós-Graduação em Ciências Farmacêuticas Sorocaba (SP) Brasil Universidade de Sorocaba (UNISO), Programa de Pós-Graduação em Ciências Farmacêuticas, Sorocaba (SP), Brasil.
Silvio Barberato-FilhoUniversidade de Sorocaba (UNISO) Programa de Pós-Graduação em Ciências Farmacêuticas Sorocaba (SP) Brasil Universidade de Sorocaba (UNISO), Programa de Pós-Graduação em Ciências Farmacêuticas, Sorocaba (SP), Brasil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The association between fast-growing mobile technologies and increasingly more mobile devices has allowed the introduction of virtual environments into daily activities. That includes the health care domain, where concepts such telemedicine, telehealth, eHealth, and mHealth have emerged. In addition to presenting these new concepts, this article aims to discuss the advancements and challenges of mobile health technologies stemming from considerations regarding development, application, legal aspects, and ethics. Because of their innovative nature, mobile health technologies entail the engagement of many actors in the journey to reach end users, covering conception, technical development, sanitary regulations, and design of clinical guidelines, having raised a great deal or interest in terms of monitoring and care across a variety of clinical conditions. However, assessment of the effectiveness and safety of mobile health technologies does not seem to involve the same methodological rigor imposed for clinical trials of drugs and other health products; still, the enthusiasm produced by this innovation counters some of the regulatory and ethics concerns relating to data protection, privacy, access to mobile devices, and technological or social inequality. Despite possible limitations, mobile technologies, as well as other telehealth resources, have produced promising results. Digital healthcare has great potential for expansion and represents an opportunity for the review of traditional practices with selection of mobile technologies for incorporation into the health care system whenever evidence-based benefits are verified.

Indexed as

delivery of health careeHealth strategiesInformation technologytelemedicinewireless technology

Identifiers

PMID35620177
PMCPMC9128660

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.